Evaluation of the Efficacy and Safety of Azeliragon (TTP488) in Patients With Mild Alzheimer's Disease
Clinical trial NCT02080364 · TERMINATED
Trial details
- NCT number
- NCT02080364
- Sponsor
- vTv Therapeutics
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-04-01
- Primary completion
- 2018-06-01
- Enrollment
- 880
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.